Glucosamine Market

Glucosamine Market Size (2023 to 2028)

The global glucosamine market size is expected to be valued at USD 855.6 million by 2028 from USD 626.3 million in 2023, growing at a CAGR of 6.44% from 2023 to 2028.

Glucosamine Market Share Insights:

• Based on form, the capsules segment held the leading share of the global market in 2022.
• Based on the product, the glucosamine hydrochloride led the market in 2022.
• Based on application, the nutritional supplement segment had the largest share of the global market in 2022.
• Based on region, North America dominated the market in 2022.

Impact of COVID-19 on the glucosamine market:

Lockdowns, travel bans, and decreased manufacturing output brought on by the COVID-19 pandemic have disrupted international supply networks. Most of the glucosamine comes from natural sources like shellfish or is synthesized. The affordability of essential components has been influenced by the constraints on logistics and transportation, potentially disrupting the supply chain and hurting the production and supply of glucosamine commodities. The expectations and purchasing behavior of customers have also changed because of the COVID-19 pandemic. While some people might have kept their joint health as a top priority and kept using glucosamine supplements, others might have switched their priorities and expenditure on additional necessary things. Concerning the tastes of specific customers and the state of the economy throughout the worldwide COVID-19 pandemic, the overall need for glucosamine products might have shifted.

Market Drivers:

The growing consumer awareness regarding bone and joint health is expected to fuel the use of glucosamine in various food and beverage products and propel market growth. To address their health concerns, consumers are moving more and more into natural and holistic methods. Customers now have an easy way to add glucosamine to their daily diets to boost skeletal and joint health organically. Global population aging is causing a spike in age-related health disorders, such as joint problems such as osteoarthritis. As people become older, keeping their joints healthy becomes more important. The demand for chitin-fortified food and beverage items has increased due to consumer knowledge of the prospective advantages of glucosamine for handling joint health issues as a supportive and preventive treatment.

The rising prevalence of chronic diseases such as diabetes and cancer contribute to the growth of the glucosamine market. Glucosamine increases insulin sensitivity, control blood sugar levels, and lessens diabetes-related inflammation. The need for glucosamine products is rising as the prevalence of diabetes keeps increasing worldwide while there is growing attention to researching natural options such as glucosamine to treat the diseases. The demand for glucosamine as a supplemental medication needed for joint health in cancer patients has increased due to the rising prevalence of cancer and the requirement for additional support during and after treatment. The rising prevalence of rheumatoid arthritis supports the glucosamine market growth. Rheumatoid arthritis is a chronic autoimmune condition known as rheumatoid arthritis which mostly impacts the joints, causing pain, swelling, and joint degeneration. For the treatment of rheumatoid arthritis symptoms and to support joint health, glucosamine is frequently taken as a dietary supplement. The need for glucosamine supplements has increased because of the increasing incidence of rheumatoid arthritis and the increased requirement for joint health care. The desire for glucosamine as an alternative medicine for joint health support has been fuelled by the increasing number of elderly people and related joint health concerns.

Furthermore, the growing aging population, technological advancements, increasing prevalence of autoimmune disorders and growing number of improvements in healthcare infrastructure and favorable initiatives from the governments of various countries promotes the market growth.

MARKET RESTRAINTS:

Side effects associated with using glucosamine and high costs associated with glucosamine products hinder the global market growth. The use of glucosamine sulfate orally has the potential to cause several issues, including headache, nausea, heartburn, diarrhea, sleepiness, and allergic reactions to the skin. It is also inappropriate for people with individual diabetes or shellfish allergies. Some prospective glucosamine alternatives, such as omega-3 fatty acids, fish liver oil, collagen, and substances such as turmeric impedes the market growth. Consumers may be significantly deterred by the rising expense of glucosamine products. Availability may be hampered by increased costs, especially for those who depend on glucosamine for overtime joint health care. Price increases could deter some customers from buying or using glucosamine products, which would limit the market's potential for expansion.

REPORT COVERAGE: 

This research report on global glucosamine market has been segmented and sub-segmented based on the following categories.

Glucosamine Market - By Form:

• Powder
• Tablets
• Capsules
• Gel
• Liquid

Based on the form, the capsules segment is expected to hold the largest share of the global glucosamine market during the forecast period. The exact amount and composition of glucosamine are made possible via capsules. The encapsulation technique guarantees that each capsule contains the necessary quantity of glucosamine, ensuring proper dosage and reliable administration of the active component.

The powder segment is estimated to register a healthy CAGR during the forecast period. Glucosamine powder has a wide range of uses and applications. It is simple to incorporate into a variety of food and beverage products, including yogurt, protein shakes, smoothies, and juices. Due to its adaptability, glucosamine can be included in customers' everyday routines in a way that suits their tastes and eating patterns.

Glucosamine Market - By Product:

• Glucosamine Hydrochloride
• N-acetyl glucosamine
• Glucosamine Sulfate
• Others

Based on the product, the glucosamine hydrochloride segment is predicated to capture the leading share of the global market during the forecast period owing to the growing use of glucosamine hydrochloride as a therapy for heart disease, stroke, back pain, and other illnesses as well as joint disorders such as osteoarthritis. Glucosamine hydrochloride does not damage people with excessive cholesterol or triglyceride levels is an additional advantage of using it.

The glucosamine sulfate segment is expected to hold a considerable share of the global market in the coming years. Numerous studies have shown that glucosamine sulfate is useful in promoting joint health and controlling the symptoms of illnesses like osteoarthritis. The beneficial findings from clinical trials include reduced pain, enhanced joint functionality, and slower joint degeneration. Its broad use and high market demand have been influenced by the availability of strong scientific data and the awareness of glucosamine sulfate's effectiveness.

Glucosamine Market- By Application:

• Pharmaceutical Drugs
• Nutritional Supplements
• Food & Beverages
• Dairy Products
• Others

Based on application, the nutritional supplement segment is expected to dominate the market during the forecast period. The growing demand for enhanced glucosamine supplements, particularly from those with long-term bone-related issues and increased use of nutritional supplements by athletes for better bone health fuel the growth rate of the nutritional supplement segment in the global market.

The pharmaceutical drugs segment is projected to grow at a healthy CAGR in the coming years. The growing incidence of joint disorders, increasing aging population, rising awareness among consumers, improvements in pharmaceutical research, higher medical expenses, and expanded distribution channels drive the growth of the pharmaceutical drugs segment in the global market.

Glucosamine Market - By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

North America is anticipated to account for the major share of the worldwide market during the forecast period. The growing aging population, increasing number of people suffering from osteoarthritis and joint pain, the availability of a wide range of glucosamine supplements in the North American market, robust distribution channels and strong consumer demand for natural health products majorly drive the growth of the glucosamine market in North America. The U.S. is expected to capture the leading share of the North American market during the forecast period owing to the large consumer base and healthcare spending and growing trend of self-care and preventive health measures among the U.S. consumers.

Europe is the second largest regional market for glucosamine and is anticipated to hold a substantial share of the global market during the forecast period. The growing awareness about joint health and dietary supplements, high prevalence of osteoarthritis and musculoskeletal conditions and stringent regulations promoting product quality and safety drive the growth of the European market. Germany had the largest share of the European market in 2022 and the lead of Germany in Europe is expected to continue throughout the forecast period. Factors such as increasing aging population, rising consumer interest in natural and alternative therapies and growing demand for dietary supplements as part of healthy aging strategies.

APAC is expected to witness the fastest CAGR among all the regions worldwide owing to the growing urbanization and rapid adoption of sedentary lifestyles contributing to joint health concerns. The growing middle-class population with higher purchasing power for health supplements and the presence of traditional medicine practices that emphasize natural remedies for health issues. China, followed by India and Japan are expected to hold the leading share of the APAC market during the forecast period owing to the rising health consciousness and preference for natural supplements among consumers.

KEY MARKET PLAYERS:

NOW Health Group, Inc., Teva Pharmaceutical Industries Ltd., Zhejiang Aoxing Biotechnology Co., Ltd., Glanbia plc., Mylan N.V., T.C. Union Group Ltd., FabriChem, Inc., Golden S Pharmaceutical Co., Ltd., Schiff Nutrition International Inc., Nutralife Health Products Inc., Panvo Organics Pvt. Ltd., Foodchem International Corporation, Ethical Naturals, Inc., Koyo Chemical Co., Ltd., Blackmores Ltd. and Koyo Chemical Co., Ltd. are some of the major companies in the global glucosamine market.